202 Newest Precision Oncology

202: The Potential of Precision Oncology

‘With the advancements in genomic technologies and tumor profiling, it is now possible to identify targetable alterations, leading to actionable results.’ Jeffrey Seitz, CEO PHIX Genomics Exploring the possibilities of the latest developments in cancer treatment. 20 years of development in genomics is now making it possible to explain why a treatment may work for […]

202: The Potential of Precision Oncology Read More »